In cases where the risks of ESA therapy outweigh the benefits, alternative treatments for anemia may be considered. These include iron supplementation, blood transfusions, and newer drugs like HIF-PH inhibitors that offer different mechanisms of action for stimulating erythropoiesis. The choice of treatment depends on the underlying cause of anemia and the patient's overall health condition.
